Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $16.2 million.

  • Surgery Partners' Change in Receivables fell 1518.32% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year decrease of 1926.91%. This contributed to the annual value of $72.1 million for FY2024, which is 5275.42% up from last year.
  • As of Q3 2025, Surgery Partners' Change in Receivables stood at $16.2 million, which was down 1518.32% from -$3.7 million recorded in Q2 2025.
  • Surgery Partners' Change in Receivables' 5-year high stood at $40.9 million during Q4 2024, with a 5-year trough of -$8.8 million in Q1 2023.
  • Its 5-year average for Change in Receivables is $10.2 million, with a median of $13.1 million in 2023.
  • In the last 5 years, Surgery Partners' Change in Receivables surged by 97500.0% in 2021 and then crashed by 34000.0% in 2023.
  • Surgery Partners' Change in Receivables (Quarter) stood at $13.7 million in 2021, then surged by 182.48% to $38.7 million in 2022, then decreased by 25.06% to $29.0 million in 2023, then surged by 41.03% to $40.9 million in 2024, then plummeted by 60.39% to $16.2 million in 2025.
  • Its Change in Receivables was $16.2 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$4.8 million in Q1 2025.